Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Национальный Фармацевтический УниверситетfiledCriticalНациональный Фармацевтический Университет
Priority to UAU201102181UpriorityCriticalpatent/UA63370U/en
Publication of UA63370UpublicationCriticalpatent/UA63370U/en
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Nitrogen Condensed Heterocyclic Rings
(AREA)
Abstract
The use of 4,3'-spiro[(2-amino-3-cyano-4,5-dihydropyrano[3,2-C]chromen-5-on)-5-methyl-2'-oxyndole] of the general formula:as nephroprotective agent.
UAU201102181U2011-02-242011-02-24Use of 4,3'-spiro[(2-amino-3-cyano-4,5-dihydropyrano[3,2-c]chromen-5-on)-5-methyl-2'-oxyndole] as nephroprotective agent
UA63370U
(en)
USE OF 4,3'-SPIRO[(2-AMINO-3-CYANO-4,5-DIHYDROPYRANO[3,2-c]CHROMEN-5-ON)-5-METHYL-2'-OXINDOLE] AS AGENT FOR PREVENTING AND TREATING ISCHEMIC LIVER LESIONS